• Japanese
  • Korean
  • Chinese
Cover Image

Global Generic Drugs Market 2014-2018

TechNavio's analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this market. The market is also witnessing an increase in mergers and acquistions. However, intense competition among vendors could squeeze profit margins, increase pricing pressure, and pose a challenge to the growth of this market.

TechNavio's report, the Global Generic Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Generic Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space include Actavis plc, Mylan Inc., Novartis International AG (Sandoz), STADA Arzneimittel AG, and Teva Pharmaceutical Industries Ltd.

Other vendors mentioned in the report are 3SBio Inc., Amgen Inc., Apotex Inc., AstraZeneca plc, Aurobindo Pharma Ltd., Baxter International Inc., Berlin-Chemie AG, Biocon Ltd., Biogen Idec Inc., Boehringer Ingelheim GmbH, Celltrion Inc., Cipla Ltd., Coherus Biosciences Inc., Daiichi Sankyo Co. Ltd., Dr. Reddy's Laboratories Ltd., Emcure Pharmaceuticals Ltd., Gedeon Richter plc, GlaxoSmithKline plc, Hospira Inc., Impax Laboratories Inc., Intas Pharmaceuticals Ltd., Lupin Ltd., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corp., Par Pharmaceutical Inc., Pfizer Inc., Ranbaxy Laboratories Ltd., Roche Holding AG, Sanofi S.A., Wockhardt Ltd., and Zydus Cadila Healthcare Ltd.

Key questions answered in this report:

  • What will the market size and growth rate be in 2018?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by key vendors?
  • What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

  • 06. Market Landscape
  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Generic Drugs Market in the US
    • 06.3.1. Market Size and Forecast
  • 06.4. Generic Drugs Market in Europe
    • 06.4.1. Market Size and Forecast
  • 06.5. Generic Drugs Market in Germany
    • 06.5.1. Market Size and Forecast
  • 06.6. Generic Drugs Market in the UK
    • 06.6.1. Market Size and Forecast
  • 06.7. Generic Drugs Market in Italy
    • 06.7.1. Market Size and Forecast
  • 06.8. Generic Drugs Market in France
    • 06.8.1. Market Size and Forecast
  • 06.9. Generic Drugs Market in Spain
    • 06.9.1. Market Size and Forecast
  • 06.10. Generic Drugs Market in China
    • 06.10.1. Market Size and Forecast
  • 06.11. Generic Drugs Market in India
    • 06.11.1. Market Size and Forecast
  • 06.12. Generic Drugs Market in Australia
    • 06.12.1. Market Size and Forecast
  • 06.13. Five Forces Analysis

07. Market Segmentation by Category

  • 07.1. Global Generic Drugs Market by Category
    • 07.1.1. Global Biosimilars Market

08. Market Segmentation by Therapeutic Applications

  • 08.1. Global Generic Drugs Market by Therapeutic Applications

09. Geographical Segmentation

  • 09.1. Global Generic Drugs Market by Geographical Segmentation
  • 09.2. Generic Drugs Market in Americas
    • 09.2.1. Market Size and Forecast
  • 09.3. Generic Drugs Market in the EMEA Region
    • 09.3.1. Market Size and Forecast
  • 09.4. Generic Drugs Market in the APAC Region
    • 09.4.1. Market Size and Forecast

10. Key Leading Countries

  • The US
  • China
  • India

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
    • 18.1.2. Mergers and Acquisitions
  • 18.2. Market Share Analysis 2013
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. Actavis plc
    • 19.1.1. Business Overview
    • 19.1.2. Business Segmentation
    • 19.1.3. Key Information
    • 19.1.4. SWOT Analysis
  • 19.2. Mylan Inc.
    • 19.2.1. Business Overview
    • 19.2.2. Business Segmentation
    • 19.2.3. Key Information
    • 19.2.4. SWOT Analysis
  • 19.3. Novartis International AG
    • 19.3.1. Business Overview
    • 19.3.2. Business Segmentation
    • 19.3.3. Key Information
    • 19.3.4. SWOT Analysis
  • 19.4. STADA Arzneimittel AG
    • 19.4.1. Business Overview
    • 19.4.2. Business Segmentation
    • 19.4.3. Key Information
    • 19.5.1. SWOT Analysis
  • 19.6. Teva Pharmaceutical Industries Ltd.
    • 19.6.1. Business Overview
    • 19.6.2. Business Segmentation
    • 19.6.3. Key Information
    • 19.6.4. SWOT Analysis

20. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Generic Drugs Market Overview
  • Exhibit 3: Global Generic Drugs Market 2013-2018 (US$ million)
  • Exhibit 4: Global Generic Drugs Market in the US 2013-2018 (US$ billion)
  • Exhibit 5: Global Generic Drugs Market in Europe 2013-2018 (US$ billion)
  • Exhibit 6: Generic Drugs Market in Europe Country Wise Market Share 2013
  • Exhibit 7: Generic Drugs Market in Germany 2013-2018 (US$ billion)
  • Exhibit 8: Generic Drugs Market in the UK 2013-2018 (US$ billion)
  • Exhibit 9: Generic Drugs Market in Italy 2013-2018 (US$ billion)
  • Exhibit 10: Generic Drugs Market in Italy 2013-2018 (US$ billion)
  • Exhibit 11: Generic Drugs Market in Spain 2013-2018 (US$ billion)
  • Exhibit 12: Generic Drugs Market in China 2013-2018 (US$ billion)
  • Exhibit 13: Generic Drugs Market in India 2013-2018 (US$ billion)
  • Exhibit 14: Generic Drugs Market in Australia 2013-2018 (US$ billion)
  • Exhibit 15: Global Generic Drugs Market Segmentation
  • Exhibit 16: Global Biosimilars Market 2013-2018 (US$ million)
  • Exhibit 17: Global Generic Drugs Market by Therapeutic Applications
  • Exhibit 18: Global Generic Drugs Market Segmentation by Therapeutic Applications 2013
  • Exhibit 19: Global Generic Drugs Market by Geographical Segmentation 2013
  • Exhibit 20: Global Generic Drugs Market in Americas 2013-2018 (US$ billion)
  • Exhibit 21: Global Generic Drugs Market in Europe 2013-2018 (US$ billion)
  • Exhibit 22: Generic Drugs Market in China 2013-2018 (US$ billion)
  • Exhibit 23: Global Generic Drugs Market by Geographical Segmentation 2013-2018 (in percentage)
  • Exhibit 24: YOY Growth Rate Comparison of the Geographic Segments in the Global Generic Drugs Market 2013-2018
  • Exhibit 25: Business Segmentation of Actavis plc
  • Exhibit 26: Business Segmentation of Mylan Inc.
  • Exhibit 27: Business Segmentation of Novartis International AG
  • Exhibit 28: Business Segmentation of STADA Arzneimittel AG
  • Exhibit 29: Business Segmentation of Teva Pharmaceutical Industries Ltd.
Show More
Pricing
Get Notified
Email me when related reports are published